Heimdall Insights

Global Female Sexual Dysfunction Treatment Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Female Sexual Dysfunction Treatment Market was valued at $600 mn. in 2025. During the forecast period 2025-2030, it is expected to grow at 11.5% CAGR, to an estimated market size of $1.0 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The Female Sexual Dysfunction (FSD) Treatment market encompasses pharmacological, hormonal, and non-hormonal interventions designed to address clinical conditions such as Hypoactive Sexual Desire Disorder (HSDD), female sexual arousal disorder, and dyspareunia. The scope includes prescription medications, integrated psychosexual counseling, and specialized medical devices, while excluding general lifestyle supplements not regulated as therapeutic treatments.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Female Sexual Dysfunction Treatment Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

Segments

  • Hormonal Therapy
  • Non-Hormonal Therapy